改善老年人多重用药依从性干预试验核心结局指标集的国际共识
本研究通过德尔菲法(三轮,参与者分别为57、53、50人)和两场名义群体技术会议(n=10),由学术人员、期刊编辑、医疗专业人员和公众参与者对13个结局进行评价,最终达成共识纳入6个核心结局:多种药物依从性、治疗负担、健康相关生活质量、医疗资源利用、不良事件与副作用、成本效果。该核心结局指标集应应用于以改善老年人适当多重用药依从性为目标的干预研究中。
要点
- 核心结局指标集包含6个结局:多种药物依从性、治疗负担、健康相关生活质量、医疗资源利用、不良事件与副作用、成本效果。
- 共识标准为≥80%参与者评为关键重要且≤15%评为不重要。
- 该核心结局指标集应用于改善老年人适当多重用药依从性的干预试验。
核心结论
- 针对改善老年人适当多重用药依从性的干预试验,应使用包含6个结局的核心结局指标集。
研究设计与样本
- 国际共识研究,采用德尔菲法(三轮,参与者分别为57、53、50人)和两场在线名义群体技术会议(n=10)。
- 利益相关者包括学术人员、期刊编辑、医疗专业人员和公众参与者。
主要发现
- 最初评价13个结局,德尔菲研究后达成共识纳入6个结局进入核心结局指标集。
- 纳入的核心结局为:多种药物依从性、治疗负担、健康相关生活质量、医疗资源利用、不良事件与副作用、成本效果。
关键数值与推荐
- 德尔菲法采用9点李克特量表,7-9分表示关键重要,1-3分表示不重要。
- 结局纳入标准为≥80%参与者评为关键重要且≤15%评为不重要。
临床怎么用
- 在针对老年人适当多重用药依从性的干预研究中,应采用该核心结局指标集进行结局评价。
- 未来工作应确定与该核心结局指标集配套使用的结局测量工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Medication non-adherence is prevalent in older people taking polypharmacy. Several interventions have been employed to improve adherence in this population. However, inconsistencies in outcomes have impeded comparisons of findings. Accordingly, this work aimed to develop a core outcome set (COS) for use in trials aiming to improve adherence to appropriate polypharmacy in older people. METHODS: A group of stakeholders, including academics, journal editors, healthcare professionals (HCPs) and public participants, evaluated 13 outcomes compiled from the literature in a Delphi study using a nine-point Likert scale ranging from 1 to 9, where higher scores (7-9) indicated critical importance and lower scores (1-3) unimportance. The resultant Delphi consensus list was discussed and voted on (yes: critical and no: unimportant) in two online nominal group technique (NGT) meetings. The NGT followed a five-stage approach: introduction, silent generation, round-robin, clarification and voting. An outcome was included if ≥80% of participants scored it critical and ≤ 15% scored it as unimportant. RESULTS: Of the 13 outcomes originally presented to participants, consensus was achieved to include six outcomes in the COS after the Delphi study (Round 1, n = 57; Round 2, n = 53; Round 3, n = 50, where 'n' represents participant numbers) and the NGT meetings (n = 10) comprising medication adherence across multiple medications, treatment burden, health-related quality of life (HRQoL), healthcare utilisation (HCU), adverse events and side effects (AEs and SEs) and cost-effectiveness. CONCLUSION: This COS should be used in intervention studies focusing on improving adherence to appropriate polypharmacy in older people. Future work should identify outcome measurement instruments to be used alongside the COS.
引用
- Al Shaker H, Barry H, Hughes C, et al. Development of a core outcome set for clinical trials targeting interventions aiming to improve adherence to appropriate polypharmacy in older people-an international consensus study. Age Ageing. 2025. PMID: 40267306. doi:10.1093/ageing/afaf102
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。